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Recently a Lancet Commission examined the future prospects of
the NHS in the wake of COVID-19. The report cites poor healthcare
capacity and chronic staff shortages as key contributing factors to the
UK’s inadequate pandemic response. Notable strengths included uni-
versal access, the goodwill of staff, and the ability to generate innova-
tive solutions - qualities that are likely to have averted an even
deeper national crisis [1].
The prosperity of the NHS is intrinsically connected to the pros-
perity of the nation. Access to healthcare influences morbidity, mor-
tality, economic activity, and whether or not social restrictions are
necessary [2,3]. Public health measures such as timely implementa-
tion of social distancing are also important to limit mortality, but
going forward it is the capacity to respond in a clinically effective and
decisive manner that is vital to diminish the threat associated with
the virus [4].
The importance of examining the national clinical response to
SARS-CoV-2 cannot be overstated. Arguably the greatest mistake of
this pandemic would be failing to prepare for the next. There are also
the looming unknowns of SARS-CoV-2 variants [5], the higher rates* Corresponding author.
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healthcare demands associated with delayed presentation of COVID-
19 pneumonia [7-11]. Improving the tolerance of society to back-
ground levels of SARS-CoV-2 will require an improved clinical
response. With this in mind, we examine one aspect of the UK’s clini-
cal response that remains in place today: restricted access to health-
care.2. The rationed response
Part of the poor clinical response to COVID-19 in the UK can be
traced back to national policies restricting access to healthcare. Early
on in the crisis the national response defaulted to a passive clinical
approach [12,13], despite international recommendations to the con-
trary [14]. UK-wide, patients were advised to stay at home, book a
SARS-CoV-2 test, and if concerned consult either an automated online
symptom checker or non-clinical telephone triage system [12,13].
Notably, thresholds for onward referral using these new and
unproven triage systems were high [15]. Equally concerning, the sub-
sequent automated safety-net advice given to the patient included
‘how to manage breathlessness at home’ [13]  a practice that would
have been inconceivable in 2019. This, what became the national
COVID-19 clinical pathway, replaced the more typical GP-led com-
munity assessment of the infected, breathless patient [16].er the CC BY license (http://creativecommons.org/licenses/by/4.0/)
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national level, regardless of local disease prevalence and even for
patients without COVID-19, target oxygen levels were reduced. This
departure from our usual standards of care was imposed nationwide
without any new evidence or revision to our established pneumonia
guidelines [17]. This meant patients with severe COVID-19 could be
left at home, or sent home, hypoxic and without any treatment or fol-
low-up. [Some localities did identify this gap in the national response
and implemented their own follow-up service for high-risk patients
who did not meet the new, higher thresholds for admission [19].
The rationale for such a passive, restricted national clinical
response to the disease is not entirely clear. It may have been a pre-
emptive rationing of healthcare; an attempt to concentrate limited
clinical resources to those in most clinical need. But acute medical
problems generally follow a different logic. Any offsetting of the
healthcare burden achieved by restricting access to clinical contact
early on in the disease is lost when patients - albeit fewer in number
- present more severely unwell further on in the course of the disease
[7-9]. A ten minute clinical assessment can quite easily become many
hours of clinical time if the opportunity to intervene early is missed.
And, a short, uncomplicated hospital stay can quite easily become a
complicated and protracted one, if treatment is delayed.
The more typical early intervention approach normally applied to
pneumonic illnesses is both clinically effective and resource-savvy
[7]. It starts with a basic medical principle: pneumonia responds
poorly to a lack of attention [7-11]. Patients who present late have
greater healthcare needs and require longer inpatient stays [8,9].
Pneumonia detected early is simpler to treat, with less need for high
dependency care, shorter hospital admissions, and less morbidity
and mortality [8-11]. Most patients do not develop COVID-19 pneu-
monia, but older adults and some vulnerable patients carry a sub-
stantive risk of developing pneumonia and a high mortality[20]. And
all adults carry an increased risk of higher post-pneumonia complica-
tions (e.g., post-COVID syndromes) when treatment is delayed and
the opportunity to prevent disease progression is missed [6]. Failure
to respect these tenets of clinical care and capitalise on the opportu-
nity to intervene early will serve only to deepen the extent and dura-
tion of the healthcare crisis.
International guidelines do not support the UK’s passive clinical
approach to SARS-CoV-2. The WHO issued guidelines in March 2020
recommending a clinical assessment be offered to all patients with
suspected or confirmed COVID-19 [14]. The UK has yet to meet those
standards. The WHO also produced similar guidelines directed at
‘resource-restricted’ countries [21]. All four UK nations have failed to
meet those standards too [22-25]. Even now, in the UK, patients with
COVID-19  suspected or confirmed  are still not offered an initial
clinical assessment or follow-up, be it remote or otherwise. The pub-
lic can still order a diagnostic test without clinical supervision, are
still triaged through an automated or non-clinical pathway, and
astonishingly, are still offered advice (and now a video) on how to
manage breathlessness at home without ever having seen or spoken
to a doctor or nurse [12,13,22-25]. Of critical concern, at the time of
writing, older adults and vulnerable patients are held to the same
pathway [22-25], despite our awareness of ‘silent hypoxia’ and the
mortality rate of the vulnerable and older COVID-19 patients [20].
These standards are substantially below those expected in the UK
and internationally, and need to be addressed.
3. Basic healthcare provision
Early in 2020, the WHO issued pandemic-specific technical guide-
lines recommending an expansion to basic healthcare provision [26].
An expanded basic healthcare capacity typically refers to an increase
in inpatient bed capacity with the accompanying increase in staffing;
although, these basic secondary care services can sometimes be pro-
vided in the community via outreach services [27]. Basic healthcarefacilities enable at-risk or deteriorating patients access to clinical
monitoring and the mainstay of treatment for COVID-19 pneumonia.
Dedicated basic care facilities also provide effective isolation for the
most infective cases and helps alleviate the fear of nosocomial spread
[26].
UK policy focused instead on expanding intensive care unit (ICU)
capacity. Basic healthcare capacity was fashioned by curtailing other
essential healthcare services. The existing NHS bed quota were used
to provide beds for COVID-19 patients and no actual increase in basic
healthcare capacity has, to this day, occurred. Indeed, together with
the effects of social distancing for infection control purposes, the NHS
suffered an 8% reduction in usable inpatient bed capacity during the
pandemic [28].
The rationale behind the UK national policy to expand only HDU/
ICU care and not expand basic healthcare provision is not entirely
clear. Pneumonia is effectively managed by preventing disease pro-
gression. Intervening early, supplemental oxygen, thrombosis pro-
phylaxis, and instigating treatments as soon as the patient is eligible
 all of which can be done in a basic healthcare setting  [10,11], lim-
its progression of disease, improves recovery times, and conserves
the high-intensity clinical areas for the small proportion of patients
who do not respond to these basic interventions [7-9]. Waiting for
patients to deteriorate and then providing care is neither effective
nor efficient.
4. An evolving clinical response
Chronic underfunding is likely at the heart of the restricted and
rationed clinical pandemic response [1]. Asking an overstretched and
historically neglected primary care service [29] to provide clinical
contact to all patients with SARS-CoV-2 is challenging without appro-
priate levels of funding and a reprioritisation of the role of the GP.
Already, remote consults [30], greater use of non-medical clinical
staff [31], and automated remote monitoring services [32] have been
implemented in some parts of the country to try and offset the addi-
tional demands on primary care, however access to these services is
limited [33].
Innovative ‘COVID Hubs’ have been developed in some parts of
the country to enable segregated and dedicated clinical support to
COVID-19 patients [34]. Unfortunately, while reducing the risk of
viral transmission and providing a route for clinical contact, COVID
Hubs do not seem to have moved beyond the passive clinical posture
underpinning the UK national clinical response. Patients typically
have no direct access to the Hubs - even COVID-19 positive patients
-, and Hubs typically do not provide any proactive outreach to high-
risk positive patients [35]. The system remains reactionary. The
national default continues to be for the public to self-isolate and, if
concerned, to utilise the online and telephone triage of NHS 111 [36].
A number of localities developed virtual wards in an attempt to
provide some follow-up for high-risk patients who had presented to
the emergency department or GP [19]. In Southampton University
Hospital, for example, both GPs and secondary care physicians man-
aged at risk COVID-19 positive (or suspected) cases in the commu-
nity, often remotely. This appears to have been relatively successful
in providing improved follow-up for patients who had already gained
access to healthcare (although controlled data is currently lacking)
[37]. Such local success with virtual wards has led to national recom-
mendations - at least in England [38] - to develop virtual wards as
part of the secondary care of the COVID-19 patient. There is though,
no contractural arrangement for healthcare trusts to provide virtual
wards and as such no specific funding [39]. Together with the passive
national clinical response to COVID-19, the impact of virtual wards
on improving access to healthcare and improving the resilience of
the NHS is likely to remain limited.
Remote monitoring has also been developed in some parts of the
UK [22,23]. This includes using an automated system for monitoring
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monitoring oxygen levels [32]. It is a welcomed, albeit not yet evi-
dence-based, intervention, likely providing an improved level of
community vigilance for those with COVID-19. Importantly, enrol-
ment in such monitoring services does not occur at the point of diag-
nosis, not even for the vulnerable or older patient. To access such
services patients must still identify their own deterioration and meet
the online or telephone triage criteria for onward referral [22,23].
The costs for monitoring the data generated and hence the patient
has also not yet been adequately met, the burden falling mainly on
primary care [39]. Again, within the passive model of care currently
in place and subsequent passive enrollment of patients onto home
monitoring services, and without a contractural obligation to provide
the service, remote monitoring is unlikely to achieve the cost savings
and healthcare resilience benefits it could.
5. Pandemic responsiveness
While a degree of restricted access to healthcare is expected during
a pandemic of this magnitude, the extent of healthcare restrictions
that occurred in the UK, and the fact they are continuing, is concerning.
Case numbers of severe infections are lower, treatment options have
improved [10,11], and yet patients with COVID-19 are still not offered
clinical follow-up, not even older or vulnerable patients. This suggests
the national clinical response lacks coordination and adaptability 
there is an inadequate pandemic responsiveness.
Triaging is a clinical activity where clinical judgement is deployed
to determine the most appropriate next step in a patient’s journey,
often under resource constraints. The skill in clinical triage is in iden-
tifying those patients who will benefit from the limited available
resources. Clinical triage is not static. It changes, often daily, often in
response to evolving knowledge and experience, and certainly in
response to local resource availability. Effective triage benefits both
patient and the healthcare service, as resources are directed where
they are likely to work, and, crucially, at the moment at which they
are most effective [40].
During this pandemic, the clinical aspect of triaging has been
substituted by a ubiquitous national strategy of using the NHS 111
online and non-clinical telephone triage service, replacing clinical
judgement with predetermined thresholds for onward referral.
Unless the thresholds for onward assessment are set low, many
opportunities to prevent disease progression will be missed, and
with it the opportunity to reduce mortality, prevent post-pneumonia
complications, and prevent prolonged and protracted hospital admis-
sions. In the UK, the thresholds for recommending any clinical con-
tact are set high, and not just for the areas suffering a surge of
infections, but for the entire nation - restricting access to care even
where healthcare demands are relatively low [15].
Ideally, and as recommended by the WHO [14,21], all patients with
suspected or confirmed SARS-CoV-2 should undergo clinical triage and
follow-up. With the pressures on the NHS and variation in SARS-CoV-2
case numbers this will not always be possible. Some adaptability will
be needed. In terms of mortality savings and optimising the flow of
patients through inpatient care - protecting ICUs and the NHS - adap-
tion should occur in relation to risk, not by automated systems or non-
clinical staff trying to determine disease severity.
Singapore has at times adapted their response based on risk. Typi-
cally, in Singapore, any member of the public can book a same day
appointment at one of 900 public health clinics (run by primary
care), receive a clinical assessment, a SARS-CoV-2 swab, and be tri-
aged home with follow-up, or referred to a dedicated secondary care
service for further assessment [41,42]. During a surge of SARS-CoV-2
cases in April 2020, Singapore’s online triage tool was changed to
advise the non-breathless, young patient to stay at home and to con-
tact their GP if symptoms hadn’t improved after three days [15].
While still a compromised response - and one that was quicklyreversed when case numbers fell -, it permitted some low-risk relief
to the healthcare service.
A dynamic and adaptable pandemic response is vital if we are to
maximise the clinical resources available. A wholesale approach to
triage is neither evidence-based nor is it likely to succeed [40]. Access
to healthcare saves lives [2,3], and timely access to healthcare saves
lives and resources [7-11]. Directing patients to the most appropriate
level of care can only be achieved if the local options for care are con-
sidered. Compromises may need to be made, but we also must accept
they are compromises, and wherever possible re-address the balance
back to our more typical, dynamic clinical approach.
6. Time to move away from the rationed response
A number of European nations have maintained direct clinical
contact for patients with confirmed or suspected COVID-19. Switzer-
land has maintained direct access to GPs, who undertake the majority
of COVID-19 patient triage [43]. Germany has also directed patients
to primary care, where a reported 85% of COVID-19 cases have been
managed. Germany has also delivered direct clinical access through
community ‘Corona Clinics’; delivered outreach services to reach the
more vulnerable patients via ‘Corona Taxi’s’, and expanded basic
healthcare capacity to offload the pressures from both primary and
secondary care facilities [44].
The current UK national clinical pathway for patients with sus-
pected COVID-19 has improved but remains passive and reactionary,
and overly reliant on existing, overstretched services. This bodes
poorly for how the UK will manage any ensuing wave of SARS-CoV-2
variants or future pandemics. Basic healthcare capacity (inpatient
bed capacity) remains lower than before the pandemic [45]. Clinical
triage does not occur at the point of suspected COVID-19, nor does it
even occur when COVID-19 is confirmed. Self-isolation and then con-
tacting NHS 111 if symptoms become concerning remains the default
advice to the public [36]. Remote monitoring has been recommended
in England and some parts of Scotland, but only those patients who
identify their own deterioration currently have a chance of enrol-
ment and there is no contractural obligation for its provision [22,23].
An improved UK response should more closely follow the WHO
technical guidelines for triage and management of COVID-19 [14,21].
Invariably this will include more dedicated primary care time to con-
tact at least the at-risk patient groups at the point of diagnosis; a ded-
icated clinical follow-up service; a home outreach service for the
most vulnerable of patients, and crucially, the capacity to admit the
deteriorating or high-risk patient. These pathways would need to be
clear to both patient and clinician, and will require additional funding
and political support to achieve universal access.
In the absence of such support, we expect the lower numbers of
older and vulnerable patients who contract SARS-CoV-2 could (and
should) still be prioritised into existing primary care pathways for
direct - be it remote or otherwise - clinical contact at the point of
diagnosis.
7. Conclusion
COVID-19 has highlighted an NHS with insufficient resources and
not enough capacity or healthcare resilience to keep society running
during a pandemic. The pressures on NHS capacity prior to the pan-
demic and the inadequate expansion in healthcare provision since,
likely mean the UK will struggle to achieve international standards
(even those of a low-resource setting), at least not in a reasonable
timeframe. Without the essential access to healthcare we lose the
opportunity to prevent disease progression and with it the opportu-
nities to save lives, prevent disability, and to more effectively safe-
guard the NHS.
Necessity has spawned potentially useful innovations. Dedicated
COVID assessment centres, remote assessments, virtual wards, and
4 D.K. Goyal et al. / The Lancet Regional Health - Europe 8 (2021) 100201remote monitoring are likely to achieve clinical care closer to pre-
pandemic standards of care while saving hospital admissions and
clinical time. However, the lack of real-world funding and therefore
contractural obligation to deliver such services, together with the
most crucial of healthcare gaps - the lack of clinical triage, clinical fol-
low-up, and a safe level of inpatient capacity - severely curtail the
benefit these innovations can achieve.
Given the challenges of delivering coordinated pandemic respon-
siveness at the national level, it may be neither wise nor  in the
acute setting  necessary to wait for an adequate national response
to these healthcare needs. It may be more prudent for localities -
COVID-19 service providers, GP practices, local healthcare authorities
- to define their own healthcare prioritisation. If so doing, we urge a
more proactive clinical posture and, at least, the minimum standard
of an initial clinical assessment and clinical follow-up to all older and
vulnerable patients who contract SARS-CoV-2.
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